SEC charges MiMedx Group with accounting fraud


Biotech company MiMedx Group and three of its former top executives have been charged with defrauding investors. In response, MiMedx reshuffled its management team, including the appointment of a new general counsel and secretary.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.